On August 25, 2009
FDA Warning Ushers GSK’s Alli Toward Graveyard of Failed Obesity Products
What the FDA giveth Glaxosmithkline’s Alli, it can also taketh away. It was just last month that GSK launched a flight of ads for its weight loss drug boasting “Lose weight the FDA aproved way.” On Monday, the FDA warned doctors and consumers they were probing a link between the drug and liver damage.
0 Comments